Clinical Trial

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections

Study acronym: VIRAL-MI
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to identify the underlying neurobiological and environmental mechanisms that influence vulnerability or resilience to mental illness in the context of infection and their contribution to severe infective outcomes in people with pre-existing mental illness. The main questions it aims to answer are: * How do viral infections influence the development of mental illness? * What neurobiological and environmental factors contribute to influence the development of mental illness following infection? * How do these factors relate to the severity of infectious illness in people with pre-existing mental disorders? Researchers will move from large population databases to well-defined, deeply characterised samples to explore the association between infection and subsequent mental health outcomes, and the biological mechanisms behind these changes. Participants's data has already been collected.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-18.
Trial Details
NCT Number NCT06945627
Lead Sponsor Sara Poletti
Conditions Severe Mental Illness, Inflammation, Viral Infections, Mood Disorders, Schizophrenia
Enrollment 408,551 participants
Start Date 2024-05-02
Primary Completion 2026-05 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-05-14